As of 2024-12-13, the EV/EBITDA ratio of GPX Medical AB (GPXMED.ST) is -5.09. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GPXMED.ST's latest enterprise value is 37.45 mil SEK. GPXMED.ST's TTM EBITDA according to its financial statements is -7.36 mil SEK. Dividing these 2 quantities gives us the above GPXMED.ST EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.8x - 10.8x | 9.2x |
| Forward P/E multiples | 9.8x - 13.6x | 10.9x |
| Fair Price | (1.83) - 1.81 | (0.35) |
| Upside | -168.5% - -32.2% | -113.1% |
| Date | EV/EBITDA |